Genetic testing

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

New research developments in the molecular genetics of cancer have led to the feasibility of cancer genetic testing. At present, genetic test results can better inform individuals at risk about appropriately tailored strategies for cancer screening and prevention. In the future, more persons will be eligible for genetic evaluation; in particular, if it is shown that patients with cancer who are carriers of germline mutations respond differently to treatments, genetic testing may be warranted. Consideration needs to be given to the appropriate delivery of genetic risk assessment and testing. There is a great potential for misinterpretation of gene test results and for adverse psychosocial consequences for patients. Genetic counseling is an important component in cancer risk assessment and management, particularly in helping persons at risk understand the implications of gene test results in the context of their experience with cancer and surveillance.

Original languageEnglish (US)
Pages (from-to)939-952
Number of pages14
JournalHematology/Oncology Clinics of North America
Volume14
Issue number4
StatePublished - 2000

Fingerprint

Genetic Testing
Neoplasms
Germ-Line Mutation
Genetic Counseling
Risk Management
Early Detection of Cancer
Genes
Molecular Biology
Research

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Genetic testing. / Petersen, Gloria M.

In: Hematology/Oncology Clinics of North America, Vol. 14, No. 4, 2000, p. 939-952.

Research output: Contribution to journalArticle

@article{1f49d61b0979473f838d1908b3c1649a,
title = "Genetic testing",
abstract = "New research developments in the molecular genetics of cancer have led to the feasibility of cancer genetic testing. At present, genetic test results can better inform individuals at risk about appropriately tailored strategies for cancer screening and prevention. In the future, more persons will be eligible for genetic evaluation; in particular, if it is shown that patients with cancer who are carriers of germline mutations respond differently to treatments, genetic testing may be warranted. Consideration needs to be given to the appropriate delivery of genetic risk assessment and testing. There is a great potential for misinterpretation of gene test results and for adverse psychosocial consequences for patients. Genetic counseling is an important component in cancer risk assessment and management, particularly in helping persons at risk understand the implications of gene test results in the context of their experience with cancer and surveillance.",
author = "Petersen, {Gloria M}",
year = "2000",
language = "English (US)",
volume = "14",
pages = "939--952",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Genetic testing

AU - Petersen, Gloria M

PY - 2000

Y1 - 2000

N2 - New research developments in the molecular genetics of cancer have led to the feasibility of cancer genetic testing. At present, genetic test results can better inform individuals at risk about appropriately tailored strategies for cancer screening and prevention. In the future, more persons will be eligible for genetic evaluation; in particular, if it is shown that patients with cancer who are carriers of germline mutations respond differently to treatments, genetic testing may be warranted. Consideration needs to be given to the appropriate delivery of genetic risk assessment and testing. There is a great potential for misinterpretation of gene test results and for adverse psychosocial consequences for patients. Genetic counseling is an important component in cancer risk assessment and management, particularly in helping persons at risk understand the implications of gene test results in the context of their experience with cancer and surveillance.

AB - New research developments in the molecular genetics of cancer have led to the feasibility of cancer genetic testing. At present, genetic test results can better inform individuals at risk about appropriately tailored strategies for cancer screening and prevention. In the future, more persons will be eligible for genetic evaluation; in particular, if it is shown that patients with cancer who are carriers of germline mutations respond differently to treatments, genetic testing may be warranted. Consideration needs to be given to the appropriate delivery of genetic risk assessment and testing. There is a great potential for misinterpretation of gene test results and for adverse psychosocial consequences for patients. Genetic counseling is an important component in cancer risk assessment and management, particularly in helping persons at risk understand the implications of gene test results in the context of their experience with cancer and surveillance.

UR - http://www.scopus.com/inward/record.url?scp=0033898258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033898258&partnerID=8YFLogxK

M3 - Article

C2 - 10949782

AN - SCOPUS:0033898258

VL - 14

SP - 939

EP - 952

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 4

ER -